BENEFITING: Pulmonary Fibrosis Foundation
EVENT DATE: Jul 14, 2013
The Aquaphor New York City Triathlon is an Olympic Distance race consisting of a 1500m swim, a 40k bike, and a 10k run.
Each year over 3,000 athletes brave the waters of the mighty Hudson River before biking along Manhattan's West Side highway. Finally, athletes put on their running shoes for a run through New York's famed Central Park!
The mission of the Pulmonary Fibrosis Foundation (PFF) is to help find a cure for idiopathic pulmonary fibrosis (IPF), advocate for the pulmonary fibrosis community, promote disease awareness, and provide a compassionate environment for patients and their families.
FluidDA Inc. is an imaging biotech company, focusing on Pulmonary Research, and develops diagnostics tools and services to diagnose IPF faster and better. FluidDA will match all gifts until the $1700 goal is reached.
Idiopathic pulmonary fibrosis (IPF) is a debilitating and almost uniformly fatal disease. IPF is defined as a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause, occurring primarily in older adults, limited to the lungs, and associated with the histopathologic and/or radiologic pattern of usual interstitial pneumonia (UIP).
1 Symptoms include exertional dyspnea and a dry cough that gradually worsen. Most patients are afflicted with progressive difficulty breathing and shortness of breath. About half the patients progress gradually while others appear to experience periods of relative stability interrupted by unpredictable acute exacerbations.
2 Survival time from diagnosis of IPF is three to five years.
3 No therapy has been approved for the treatment of IPF in the US, though several promising clinical candidates are under investigation.